Condition: Mitral Regurgitation · Mitral Valve Insufficiency · Sponsor: Edwards Lifesciences
This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
This description comes directly from the study's public registry record.
Edwards TMTT Clinical Affairs · +1 (949) 250-2500 · TMTT_Clinical@edwards.com
Always discuss trial participation with your own doctor first.
| Heart Center Hospital | Huntsville, Alabama, United States | Active Not Recruiting |
| Banner University Medical Center | Phoenix, Arizona, United States | Active Not Recruiting |
| Saint Josephs Hospital Medical Center Dignity Health | Phoenix, Arizona, United States | Active Not Recruiting |
| TMC Healthcare | Tucson, Arizona, United States | Withdrawn |
| Scripps Health | La Jolla, California, United States | Active Not Recruiting |
| Good Samaritan Hospital | Los Angeles, California, United States | Active Not Recruiting |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Active Not Recruiting |
| Kaiser Sunset LA | Los Angeles, California, United States | Active Not Recruiting |
| Saint Joseph Hospital | Orange, California, United States | Withdrawn |
| California Pacific Medical Center | San Francisco, California, United States | Active Not Recruiting |
| UC Health Northern Colorado (Medical Center of the Rockies) | Loveland, Colorado, United States | Active Not Recruiting |
| Delray Medical Center | Delray Beach, Florida, United States | Withdrawn |
+ 56 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04153292